Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon Alfa-2b in advanced renal cell carcinoma

Michael B. Atkins, Joseph Sparano, Richard I. Fisher, Geoffrey R. Weiss, Kim A. Margolin, Kenneth I. Fink, Larry Rubinstein, Arthur Louie, James W. Mier, Rasim Gucalp, Jeffrey A. Sosman, David H. Boldt, James H. Doroshow, Frederick R. Aronson, Mario Sznol

Research output: Contribution to journalArticlepeer-review

191 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon Alfa-2b in advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences